Wafra Inc. Has $34.18 Million Holdings in Danaher Co. (NYSE:DHR)
Wafra Inc. raised its holdings in Danaher Co. (NYSE:DHR) by 1,242.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 258,892 shares of the conglomerate’s stock after buying an additional 239,613 shares during the period. Danaher comprises about 1.2% of Wafra Inc.’s holdings, making the stock its 7th largest position. Wafra Inc.’s holdings in Danaher were worth $34,179,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of DHR. HL Financial Services LLC grew its holdings in shares of Danaher by 0.4% during the first quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock worth $2,528,000 after buying an additional 79 shares during the last quarter. Cornerstone Advisors Inc. grew its holdings in shares of Danaher by 2.9% during the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock worth $367,000 after buying an additional 79 shares during the last quarter. First Personal Financial Services grew its holdings in shares of Danaher by 13.7% during the first quarter. First Personal Financial Services now owns 664 shares of the conglomerate’s stock worth $88,000 after buying an additional 80 shares during the last quarter. Carroll Financial Associates Inc. grew its holdings in shares of Danaher by 5.6% during the first quarter. Carroll Financial Associates Inc. now owns 1,534 shares of the conglomerate’s stock worth $202,000 after buying an additional 82 shares during the last quarter. Finally, Cookson Peirce & Co. Inc. grew its holdings in shares of Danaher by 1.8% during the first quarter. Cookson Peirce & Co. Inc. now owns 4,710 shares of the conglomerate’s stock worth $622,000 after buying an additional 83 shares during the last quarter. Institutional investors own 78.93% of the company’s stock.
In related news, Chairman Mitchell P. Rales purchased 1,900 shares of Danaher stock in a transaction dated Friday, May 10th. The stock was bought at an average cost of $130.78 per share, for a total transaction of $248,482.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Donald J. Ehrlich sold 5,000 shares of Danaher stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $132.95, for a total transaction of $664,750.00. Following the sale, the director now owns 100,603 shares of the company’s stock, valued at $13,375,168.85. The disclosure for this sale can be found here. In the last 90 days, insiders sold 453,448 shares of company stock valued at $59,724,640. 11.40% of the stock is owned by insiders.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 EPS for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.06. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 12.04% and a return on equity of 11.61%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.99 earnings per share. Analysts expect that Danaher Co. will post 4.77 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 dividend on an annualized basis and a yield of 0.49%. Danaher’s payout ratio is currently 15.04%.
A number of research firms recently issued reports on DHR. Piper Jaffray Companies began coverage on Danaher in a report on Tuesday. They set a “neutral” rating and a $148.00 price target on the stock. Zacks Investment Research raised Danaher from a “sell” rating to a “hold” rating in a report on Monday, May 6th. Wolfe Research began coverage on Danaher in a report on Thursday, May 30th. They set an “outperform” rating on the stock. Needham & Company LLC reissued a “buy” rating and set a $141.00 price target (up previously from $138.00) on shares of Danaher in a report on Wednesday, April 17th. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and set a $140.00 price target on shares of Danaher in a report on Monday, March 4th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Danaher currently has a consensus rating of “Buy” and a consensus target price of $133.00.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Special Dividends
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.